A Revosyl Lecture Titled " EUROPA Study - PERTINENT Results " in Aleppo

Wednesday, September 28, 2011

Ibn Al Haytham Pharmaceutical Industries presented a lecture titled "EUROPA Study - PERTINENT Results" on Wednesday evening 28/09/2011 at Dar Zamaraya Hotel in Aleppo for the resident internists and cardiologists doctors at Ibn Rushid Hospital . The attendance were about thirty doctors .

The Medical Representative of Revosyl , Ph. Ahmad Haji , delivered the lecture in which he talked about the importance of Revosyl in the treatment of coronary artery disease and its superiority on other ACE inhibitors .

It's worth mentioning that , Ibn Al Haytham Pharmaceutical Industries , is regarded as one of the pioneer companies in adopting studies about Revosyl efficacy , safety and resistance on more than 1200 patients in cooperation with 150 doctors from all over Syria who adopted REST Study .

For more information , you can visit the following link : REST - Revosyl Postmarketing Surveillance Trial